I. Hirsch and M. Brownlee, Should minimal blood glucose variability become the gold standard of glycemic control?, Journal of Diabetes and its Complications, vol.19, issue.3, pp.178-181, 2005.
DOI : 10.1016/j.jdiacomp.2004.10.001

D. Deiss, J. Bolinder, and J. Riveline, Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring, Diabetes Care, vol.29, issue.12, pp.2730-2732, 2006.
DOI : 10.2337/dc06-1134

I. Hirsch, J. Abelseth, and B. Bode, Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study, Diabetes Technology & Therapeutics, vol.10, issue.5, pp.377-383, 2008.
DOI : 10.1089/dia.2008.0068

O. Connell, M. A. Donath, S. , O. Neal, and D. N. , Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial, Diabetologia, vol.114, issue.7, pp.1250-1257, 2009.
DOI : 10.1007/s00125-009-1365-0

D. Raccah, V. Sulmont, and Y. Reznik, Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: The RealTrend study, Diabetes Care, vol.32, issue.12, pp.2245-2250, 2009.
DOI : 10.2337/dc09-0750

URL : https://hal.archives-ouvertes.fr/hal-00448802

R. M. Bergenstal, T. W. Ahmann, and A. , Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes, New England Journal of Medicine, vol.363, issue.4, pp.311-320, 2010.
DOI : 10.1056/NEJMoa1002853

J. Riveline, P. Schaepelinck, and L. Chaillous, Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: A 1-year multicenter study, Diabetes Care, vol.35, issue.5, pp.965-971, 2012.
DOI : 10.2337/dc11-2021

J. Pickup, S. Freeman, and A. Sutton, Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data, BMJ, vol.343, issue.jul07 1, p.3805, 2011.
DOI : 10.1136/bmj.d3805

S. Garg, M. Voelmle, and C. Beatson, Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy: A prospective 6-month study, Diabetes Care, vol.34, issue.3, pp.574-579, 2011.
DOI : 10.2337/dc10-1852

T. Battelino, M. Phillip, and N. Bratina, Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes, Diabetes Care, vol.34, issue.4, pp.795-800, 2011.
DOI : 10.2337/dc10-1989

R. M. Bergenstal, K. D. Garg, and S. K. , Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia, New England Journal of Medicine, vol.369, issue.3, pp.224-232, 2013.
DOI : 10.1056/NEJMoa1303576

T. T. Ly, N. J. Retterath, and A. , Reduction of severe hypoglycemia with sensoraugmented insulin pump therapy and automated insulin suspension in patients with type 1 diabetes, Diabetes, vol.62, issue.1, p.228, 2013.

A. Ceriello, Postprandial Hyperglycemia and Diabetes Complications: Is It Time to Treat?, Diabetes, vol.54, issue.1, pp.1-7, 2005.
DOI : 10.2337/diabetes.54.1.1

S. Garg, H. Zisser, and S. Schwartz, Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor: A randomized controlled trial, Diabetes Care, vol.29, issue.1, pp.44-50, 2006.
DOI : 10.2337/diacare.29.01.06.dc05-1686

A. Cemeroglu, R. Stone, and L. Kleis, Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit, Pediatric Diabetes, vol.7, issue.3, pp.182-187, 2010.
DOI : 10.1111/j.1399-5448.2009.00549.x

J. Halford and C. Harris, Determining Clinical and Psychological Benefits and Barriers with Continuous Glucose Monitoring Therapy, Diabetes Technology & Therapeutics, vol.12, issue.3, pp.201-205, 2010.
DOI : 10.1089/dia.2009.0121

R. R. Peyrot and M. , Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump, J Diabetes Sci Technol, vol.3, pp.1402-1410, 2009.

E. S. Huang, O. Grady, M. Basu, and A. , The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes, Diabetes Care, vol.33, issue.6, pp.1269-1274, 2010.
DOI : 10.2337/dc09-2042

R. Mcqueen, S. Ellis, and J. Campbell, Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes, Cost Effectiveness and Resource Allocation, vol.9, issue.1, p.13, 2011.
DOI : 10.2337/diacare.28.3.617

J. Devries, Continuous glucose monitoring: coming of age?, European Journal of Endocrinology, vol.166, issue.1, pp.1-4, 2012.
DOI : 10.1530/EJE-10-1127

I. Hirsch, Realistic Expectations and Practical Use of Continuous Glucose Monitoring for the Endocrinologist, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.7, pp.2232-2238, 2009.
DOI : 10.1210/jc.2008-2625

O. Connell, M. Donath, S. , O. Neal, and D. , Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial, Diabetologia, vol.114, issue.7, pp.1250-1257, 2009.
DOI : 10.1007/s00125-009-1365-0

J. Jenkins, B. Krishnamurthy, and J. Best, Evaluation of an Algorithm to Guide Patients With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion on How to Respond to Real-Time Continuous Glucose Levels: A randomized controlled trial, Diabetes Care, vol.33, issue.6, pp.1242-1248, 2010.
DOI : 10.2337/dc09-1481

J. Jenkins, B. Krishnamurthy, and J. Best, An Algorithm Guiding Patient Responses to Real-Time-Continuous Glucose Monitoring Improves Quality of Life, Diabetes Technology & Therapeutics, vol.13, issue.2, pp.105-109, 2011.
DOI : 10.1089/dia.2010.0139

B. Guerci, S. Rudoni, and E. Bonnemaison, P1122 ??valuation de l???observance ?? la mesure en continu du glucose dans le cadre de l???accompagnement du patient diab??tique de type 1 trait?? par pompe ?? insuline, Diabetes & Metabolism, vol.39, issue.1, p.60, 2013.
DOI : 10.1016/S1262-3636(13)71868-8

Y. Reznik and M. Joubert, La mesure en continu du glucose: quel impact sur l'équilibre glycémique? Quelles indications? Comment l'utiliser en pratique? Mises au point cliniques d, Endocrinologie, vol.2010, pp.107-123

P. Benhamou, B. Catargi, and B. Delenne, Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: Consensus of experts from SFD, EVADIAC and SFE, Diabetes & Metabolism, vol.38, issue.4, pp.67-83, 2012.
DOI : 10.1016/S1262-3636(12)71538-0

. Rapport-de-l-'oms-europe, Therapeutic Patient Education ? Continuing Education Programmes for health care providers in the field of chronic disease, 1996.

A. Grimaldi, Education thérapeutique : questions et controverses. Education thérapeutique : la mise en oeuvre. Paris : Editions scientifiques L&C, 2012.

H. Décret-d-'application-de-la-loi, JORF n°0245 du 21 octobre 2010

P. Benhamou, M. Muller, S. Lablanche, and I. Debaty, La télémédecine au service de la prise en charge des patients diabétiques. Développements actuels et conditions du succès. Education thérapeutique et progrès techniques, 2013.

G. Charpentier, P. Benhamou, and D. Dardari, The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study), Diabetes Care, vol.34, issue.3, pp.533-539, 2011.
DOI : 10.2337/dc10-1259

URL : https://hal.archives-ouvertes.fr/inserm-00628821

R. Mazze, B. Akkerman, and J. Mettner, An overview of continuous glucose monitoring and the ambulatory glucose profile, Minn Med, vol.94, issue.8, pp.40-44, 2011.

R. Hovorka, K. Kumareswaran, and J. Harris, Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies, BMJ, vol.342, issue.apr13 5, p.1855, 2011.
DOI : 10.1136/bmj.d1855

M. Breton, A. Farret, and D. Bruttomesso, Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia, Diabetes, vol.61, issue.9, pp.2230-2237, 2012.
DOI : 10.2337/db11-1445